middle.news

BlinkLab Advances FDA Autism Trial and Launches Morocco Screening Program

8:14pm on Friday 15th of May, 2026 AEST Healthcare
Read Story

BlinkLab Advances FDA Autism Trial and Launches Morocco Screening Program

8:14pm on Friday 15th of May, 2026 AEST
Key Points
  • Completed onboarding of 10 US clinical sites for FDA autism trial
  • First participant enrolled in pivotal FDA 510(k) validation study
  • Launched Morocco’s government-led nationwide autism screening
  • Strengthened US scientific influence via publication and partnerships
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Blinklab (ASX:BB1)
OPEN ARTICLE